Back to search

Biotechflow Ltd

07454017

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

CHEDWORTH HOUSE, STROUD, GL5 1BD
Incorporated 29/11/2010

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

21100
Manufacture of basic pharmaceutical products
71122
Engineering related scientific and technical consulting activities
72110
Research and experimental development on biotechnology
74901
Environmental consulting activities

Officers

Dr Martin John Hofmann

director · Since 29/11/2010

MANAGING DIRECTOR

BRITISH · ENGLAND · Age 69

Also on 1 other board

Persons with Significant Control

Dr Martin John Hofmann

75–100% shares

British · England · Age 69

Chedworth House, 8 Lansdown, Stroud, GL5 1BD

Notified 06/04/2016

CompanyRankvs 173+ SIC 21100 peers
70

Financial strength80th percentile among SIC peers · 20/25
Employees0th percentile among SIC peers · 0/15
LiquidityCurrent ratio 3.32× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength20/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£143k

Balance sheet strength

Cash

£54

Cash in the bank

Net Current Assets

£168k

Working capital

Current Assets

£240k

Current Liabilities

£72k

Fixed Assets

£2k

Debtors

£240k

Tax at Year End(2023)

Corp tax-£15k

Balance Sheet

Assets less current liabilities£170k
Signed by Martin Hofmann 18/12/2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20253.32-£51k
20243.18-£110k
20237.01-£210k
20225.02+£39k
20211.45+£343k
20202.38-£16k
20192.95

Derived from filed accounts. Not audited figures.